American Association of Hip and Knee Surgeons
Acetaminophen in Total Joint Arthroplasty
Ce document comprend 3 recommandations et 20 références.
Contenu en anglais
Synthèse
This clinical practice guideline evaluates the efficacy and safety of perioperative intravenous and oral acetaminophen for pain management and opioid consumption reduction in patients undergoing primary total joint arthroplasty.
The guidelines address common questions related to the efficacy and safety of acetaminophen in primary TJA. They aim to reduce practice variation by establishing multidisciplinary evidence-based recommendations.
Messages clés
Administration of IV or oral acetaminophen reduces pain and opioid consumption during the perioperative period of a primary TJA.
Oral acetaminophen is recommended after discharge as part of a multimodal pain regimen.
Administration of IV or oral acetaminophen is safe and does not increase the risk of complications following primary TJA.
Recommandations
Guideline Question 1
Administration of IV or oral acetaminophen reduces pain and opioid consumption during the perioperative period of a primary TJA.
Patients concernés: Patients undergoing primary TJASituation: Postoperative pain and opioid consumption
Guideline Question 2
In the absence of reliable evidence, it is the opinion of the workgroup that oral acetaminophen may be used after discharge as part of a multimodal pain regimen, as it is a low-cost and low-risk treatment for pain after discharge from a primary TJA.
Patients concernés: Patients undergoing primary TJASituation: Postoperative pain after discharge
Guideline Question 3
Administration of IV or oral acetaminophen does not increase the risk of complications following primary TJA.
Patients concernés: Patients undergoing primary TJASituation: Postoperative complications
